Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

NCT06710210 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Diffuse Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)

Interventions

DEVICE: PCI with a bioresorbable scaffold and drug-coated balloon(s)
DEVICE: PCI with drug-eluting stent(s)

Sponsor

University Hospital, Geneva

Collaborators

[object Object]